11/11/2015 - 11:13am

As 2015 draws to a close, the year is on track to be one in which the value of the branded drugs losing their patent protection approaches an all-time high. The dozens of drugs that will have lost their patent protection this year are estimated to have global sales of $44 billion a year — the highest total since $53 billion worth of medications went off patent in 2012.

11/11/2015 - 11:13am

Rapidly rising prices for many generics, regulations that could restrict patients’ access to these medications, a Food and Drug Administration backlog in getting new drugs approved and market consolidation that is reducing competition are all making some wonder how much longer generics will continue to be affordable.

11/11/2015 - 11:12am

Usually it takes some time for any individual’s full impact on their company, their profession and their industry to come into focus after that person has moved on.

Such may be the case with Robert I. Thompson, who stepped down Sept. 18 from his position as EVP of pharmacy at Rite Aid.

11/11/2015 - 11:11am

As health care continues to shift to an evidence-based model, ensuring patients are on the right therapy is a critical part of delivering improved health outcomes. Enter MD Labs and the company’s RxIGHT Pharmacogenetic test,

11/10/2015 - 3:17pm

New Jersey Gov. Chris Christie this week signed legislation allowing pharmacists to subsistute FDA-approved biosimilar products for biologics, and Generic Pharmaceutical Association voiced its support for the move. 

11/10/2015 - 12:31pm

Teva Canada was granted approval for its Avelox generic by Health Canada on Tuesday. 

11/10/2015 - 10:24am
In order to hit the 120 mm Hg systolic blood pressure target, the findings also noted that an average of one additional medication was required for the lower target.
11/10/2015 - 10:17am

Patients with less than 15 nanograms of vitamin D per milliliter of blood were 35% more likely to have heart disease. 

11/10/2015 - 9:35am

Pedometers, interventions and goals combined all helped improve activity by one-time sedentary people with RA by 159%, study finds.